Although liraglutide is the most studied GLP-1 agonist in psychiatric patients and is available in a generic form, it requires daily dosing and is less effective than the branded, once-weekly GLP-1 agonists semaglutide and tirzepatide.
Others reach 2.4mg and find the side effects too burdensome, stepping back down to 1.7mg for a better balance between efficacy and tolerability
The most reliable and easy rule is: Eat your goal weight in grams of protein per day
its not currently prescribable through legitimate compounding pharmacies
Mounjaro is also approved for the treatment of type 2 diabetes
Meyer S, Fuchs TJ, Bosserhoff AK, Hofstadter F, Pauer A, Roth V et al